Immunovant IMVT
$31.77 −$0.75 (-2.31%)
Market closed · Nov 22, 5:10 am ET · Last extended-hours $31.51 -0.82%
Open$32.26
Prev close$32.52
Day range$31.61 – $32.77
Volume704.9K
Market cap$6.57B
P/E (TTM)–
Dividend yield–
IMVT Stock News
Headlines matching Immunovant or the IMVT ticker, most recent first.
- LifeSci Capital Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $53
- Bernstein Initiates Immunovant(IMVT.US) With Hold Rating, Announces Target Price $37
- Truist Financial Maintains Immunovant(IMVT.US) With Hold Rating
- H.C. Wainwright Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $41
- Piper Sandler Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $66
- A Quick Look at Today's Ratings for Immunovant(IMVT.US), With a Forecast Between $41 to $66
- H.C. Wainwright Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $41 Positive
- J.P. Morgan Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $50 Positive
- Stifel Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $57 Positive
- J.P. Morgan Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $50
- J.P. Morgan Sticks to Their Buy Rating for Immunovant (IMVT)
- LifeSci Capital Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $53 Positive
- Citi Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $61 Positive
- J.P. Morgan Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $47 Positive
- H.C. Wainwright Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $40
No comments yet — be the first to weigh in on IMVT.
Sign in to join the discussion.